日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

治疗耐药性转移性前列腺癌中复发的免疫原性新抗原及其同源T细胞受体。

Gumpert Nofar, Sagie Shira, Arnedo-Pac Claudia, Babu Tomer, Weller Chen, Gonzalez-Perez Abel, Wang Yuan, Michel Todó Lucas, Levy Ronen, Chen Xi, Greenberg Polina, Dayan-Rubinov Maria, Yakubovich Elizabeta, Wasserman-Bartov Talya, Zerbib Mirie, Gong Jianhui, Rebernick Ryan J, Oliveira Tercero Anna, Agundez Muriel Laura, Benedek Gil, Kedmi Merav, Oren Roni, Ben-Dor Shifra, Levin Yishai, Troyanskaya Olga G, Munzur Aslı D, Wyatt Alexander W, Cieslik Marcin P, Quigley David A, Van Allen Eliezer M, Anandasabapathy Niroshana, Mateo Joaquin, Yang Xinbo, Martínez-Jiménez Francisco, Lopez-Bigas Nuria, Samuels Yardena

A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

双阴性前列腺癌亚型易受SWI/SNF靶向降解分子的影响

Thienger, Phillip; Paassen, Irene; Yao, Xiaosai; Rubin, Philip D; Lehner, Marika; Lillis, Nicholas; Benjak, Andrej; Shah, Sagar R; Leung, Alden King-Yung; de Brot, Simone; Naveed, Alina; Daniel, Bence; Shi, Minyi; Tremblay, Julien; Triscott, Joanna; Cassanmagnago, Giada Andrea; Bolis, Marco; Mela, Lia; Beltran, Himisha; Chen, Yu; Piscuoglio, Salvatore; Yu, Haiyuan; Ng, Charlotte K Y; Quigley, David A; Yauch, Robert L; Rubin, Mark A

Landscape of Allele-Specific Expression in Prostate Cancer Reveals Recurrent, Stage-Specific Events in AR Signaling and Resistance Pathways

前列腺癌等位基因特异性表达图谱揭示了AR信号通路和耐药通路中反复出现的、阶段特异性的事件

Tsui, Margaret; Hu, Kevin; Song, Hanbing; Hsu, Sarah C; Chen, Yih-An; Nuniz, Lorraine; Pham, Julia H; Chang, Chih-Hao; Hui, Keliana S F; Quigley, David A; Li, Jingjing; Huang, Franklin W

When tuberculosis turns critical: a rare constellation of severe complications

结核病危重症:罕见的一系列严重并发症

Afzal, Zainab; Quigley, David; Hogan, John; Murphy, Fiona; Ghasemi, Reza

An uncommon cancer mimic diagnosed via endobronchial ultrasound

通过支气管内超声诊断出一种罕见的癌症模拟疾病

Byrne, Louise; Quigley, David; O'Connell, Finbarr; Nadarajan, Parthiban

Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer

FOR46 (FG-3246) 是一种靶向 CD46 的免疫调节抗体药物偶联物,用于治疗转移性去势抵抗性前列腺癌患者,这是一项 I 期首次人体研究。

Aggarwal, Rahul R; Vuky, Jacqueline; VanderWeele, David; Rettig, Matthew; Heath, Elisabeth I; Quigley, David; Huang, Jiaoti; Chumber, Arun; Cheung, Alexander; Foye, Adam; Leung, Stanley; Abbey, Jill; Dorr, Andrew; Nasoff, Marc; Hunter, John; Wang, Steven; Flavell, Robert R; Fong, Lawrence; Liu, Bin; Small, Eric J

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

晚期前列腺癌表型亚型的个体内部表观遗传异质性

Mizuno Kei, Ku Sheng-Yu, Venkadakrishnan Varadha Balaji, Bakht Martin K, Sigouros Michael, Chan Joanna, Trigos Anna, Driskill Jordan H, Manohar Jyothi, King Abigail, Presser Adam G, Kim Min Jin, Tewari Alok K, Long Henry W, Quigley David, Choueiri Toni K, Balk Steven, Hill Sarah, Mosquera Juan Miguel, Einstein David, Sandhu Shahneen, Taplin Mary-Ellen, Beltran Himisha

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

抗体和 CAR 介导的巨噬细胞毒性的可利用机制

Liu Tianyi, Zhang Meng, Farsh Tatyanah, Li Haolong, Kishishita Audrey, Barpanda Abhilash, Leung Stanley G, Zhu Jun, Jung Hyuncheol, Hua Junjie Tony, Zhu Xiaolin, Kim Alexander B, Goo Young Ah, Son Minsoo, Kim Jaenyeon, Subramanian Aish, Sjöström Martin, Fuh Katherine C, Chapman Jocelyn S, Carnevale Julia, Gilbert Luke A, Lakkaraju Aparna, Bruno Peter M, Quigley David, Wiita Arun P, Feng Felix Y, DeSelm Carl J

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J